Wockhardt shares gain after UK MHRA says no critical observations at drug plant

By: | Updated: October 6, 2015 4:39 PM

Wockhardt shares were trading over 2 per cent up after the company said that UK's health regulator Medicines and Healthcare Products Regulatory Agency has found "no critical observations" at its L-1 Chikalthana drug manufacturing plant.

WockhardtThe UK’s health regulator Medicines and Healthcare Products Regulatory Agency (MHRA) inspected Wockhardt’s L-1 Chikalthana drug manufacturing plant and “there were no critical observations, the company said in a statement on Monday.

Wockhardt shares were trading over 2 per cent up on Tuesday after the company said that UK’s health regulator Medicines and Healthcare Products Regulatory Agency (MHRA) has found “no critical observations” at its L-1 Chikalthana drug manufacturing plant.

“The UK’s health regulator Medicines and Healthcare Products Regulatory Agency (MHRA) inspected Wockhardt’s L-1 Chikalthana drug manufacturing plant and “there were no critical observations,” the company said in a statement on Monday.

At 11.12 am, Wockhardt shares were yup 2.89 per cent up at Rs 1585.65. Sensex was up 84.43 points at 26,869.98 during the same time. Wockhardt shares closed 2.92 per cent up at Rs 1586.20

The MHRA withdrew the Chikalthana plant’s quality certificate two years ago, citing quality control lapses.

Imports from the plant have been banned by the US Food and Drug Administration since November 2013.

With Reuters inputs

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition